Therefore, we suggest that Wnt5a levels can be a prognostic bio-marker in patients with sepsis and that serial measurements of this protein can help identify high-risk patients with persistent AKI and adverse clinical outcomes. The gene discussed is WNT5A; the disease is acute kidney injury.